Dr. Charles S. Markle, M.D.
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- Medical College of Georgia School of Medicine (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 842
Licensed in Alabama since 1999, according to the Alabama Board of Medical Examiners and Medical Licensure Commission. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Medical College of Georgia School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
AL license 22829 (first issued 1999; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mobile Infirmary Medical Center Mobile, AL
- Thomas Hospital Fairhope, AL
- Singing River Health System Pascagoula, MS
- Springhill Medical Center Mobile, AL
- North Baldwin Infirmary Bay Minette, AL
Medical groups
- Coastal Neurological Institute PC (16 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 842
- Services billed
- 27,553
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 24,246 | 36 |
| Established patient office or other outpatient visit, 30-39 minutes | 574 | 373 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 348 | 150 |
| Established patient office or other outpatient visit, 20-29 minutes | 256 | 213 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 216 | 100 |
| New patient office or other outpatient visit, 60-74 minutes | 91 | 91 |
| Injection, ketorolac tromethamine, per 15 mg | 84 | 31 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 81 | 74 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 78 | 76 |
| Measurement of brain wave activity (eeg), awake and drowsy | 72 | 71 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Mobile, AL | 841 |
| Donepezil Hcl Other prescribers in Mobile, AL | 431 |
| Memantine Hcl Other prescribers in Mobile, AL | 350 |
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Mobile, AL | 315 |
| Topiramate Other prescribers in Mobile, AL | 273 |
| Clonazepam Other prescribers in Mobile, AL | 250 |
| Rizatriptan (rizatriptan benzoate) Other prescribers in Mobile, AL | 219 |
| Duloxetine Hcl Other prescribers in Mobile, AL | 213 |
| Trazodone Hcl Other prescribers in Mobile, AL | 206 |
| Pregabalin Other prescribers in Mobile, AL | 203 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 31 companies reported 273 payments worth $13,733 in total to this clinician.
| AbbVie Inc. | $10,431 |
|---|---|
| Lundbeck LLC | $378 |
| Novartis Pharmaceuticals Corporation | $373 |
| UCB, Inc. | $340 |
| Pfizer Inc. | $231 |
| Eisai Inc. | $213 |
| Janssen Biotech, Inc. | $211 |
| EMD Serono, Inc. | $201 |
| Compensation for services other than consulting (speaking, faculty) | $9,056 |
|---|---|
| Food and Beverage | $4,504 |
| Education | $99.99 |
| Travel and Lodging | $72.80 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $2,625 |
| AbbVie Inc. Apr 18, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA; UBRELVY · NEUROSCIENCE | $2,625 |
| AbbVie Inc. Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $2,625 |
| AbbVie Inc. Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $1,181 |
| Janssen Biotech, Inc. Dec 4, 2025 | Education in-kind | $99.99 |
| AbbVie Inc. Nov 18, 2025 | Travel and Lodging QULIPTA · NEUROSCIENCE · travel to BAY MINETTE, AL · in-kind | $47.60 |
| AbbVie Inc. Mar 20, 2025 | Travel and Lodging QULIPTA; UBRELVY · NEUROSCIENCE · travel to MOBILE, AL · in-kind | $16.80 |
| AbbVie Inc. Aug 25, 2025 | Travel and Lodging QULIPTA · NEUROSCIENCE · travel to MOBILE, AL · in-kind | $8.40 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.